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Hypoxia induces intercellular adhesion molecule-i on cultured human
tubular cells. The adverse effects of acute renal ischemia are partly
mediated through an infiltration of inflammatory cells into the tubuloint-
erstitium. The expression of adhesion molecules such as intercellular
adhesion molecule-i (ICAM-1) by resident renal cells (endothelial cells
and tubular cells) may facilitate this process. We investigated whether
hypoxia stimulates the expression of ICAM-1 by cultured human proximal
tubular cells (HPTC). Hypoxic culture conditions (P02 < 4 kPa) stimu-
lated the expression of ICAM-l by HPTC in a time-dependent manner
(P < 0.0001) as demonstrated by quantitative flow eytometry analysis.Quantitative PCR demonstrated an increase in ICAM-1 transcription.
Re-oxygenation of tubular cells did not increase ICAM-1 expression
further. TNFa concentration in culture supernatants increased with
hypoxia, but blocking experiments demonstrated that TNFa was not
implicated in hypoxia-induced expression of ICAM-1. Furthermore, the
cytokines IL-6 and IL-113 were not involved, but the effect of hypoxia was
blocked by PDTC, an antioxidant that may inhibit the activation of the
transcription factor NF-KB. These data demonstrate that hypoxia is a
stimulus that induces the synthesis and expression of the adhesion
molecule ICAM-I, presumably via the activation of NF-KB.
Ischemic damage to both native kidneys and kidneys after renal
transplantation is a common clinical problem. Following an
episode of renal ischemia, there is a marked infiltration of
leukocytes into the tubulointerstitium, which contributes to isch-
emia-reperfusion injury [1—4]. Renal proximal tubular cells are
known to express adhesion molecules, such as intercellular adhe-
sion molecule-i (ICAM-1) and vascular cell adhesion molecule-i
(VCAM-1), in a variety of pathological conditions including
transplant rejection and glomerulonephritis [1, 4, 5]. It is thought
that the expression of these adhesion molecules on the cell surface
is required to mediate the adhesion of leukocytes to tubular cells.
In an experimental model of renal ischemia and reperfusion in the
rat, administration of an anti-ICAM-1 antibody has been shown to
preserve renal function [21. Furthermore, a protective effect of
antisense oligonucleotides for IcAM-1 has been demonstrated in
reperfusion injury of the kidney [6]. Also, in clinical renal
transplantation the administration of anti-ICAM-1 antibodies
protects against renal dysfunction and reduces the occurrence of
Received for publication October 2, 1996
and in revised form January i7, 1997
Accepted for publication January 20, 1997
© 1997 by the International Society of Nephrology
rejection [7]. The benefit seen with the use of anti-ICAM-1 in
renal transplantation could, in part, result from a protective effect
of this antibody on hypoxia-reperfusion injury [2, 4]. In vitro, the
expression of ICAM-1 and VCAM-1 by tubular cells in culture is
stimulated by cytokines [interleukin-1/3, tumor necrosis factor-a
(TNF-a) and interferon-yl [1, 4, 8—12]. This is dependent on
protein kinase C since cytokine-stimulated adhesion molecule
expression can be inhibited by inhibitors of protein kinase C and
be mimicked by the use of protein kinase C agonists [13, 14].
Tubular epithelial cells are also able to produce a variety cyto-
kines, including TNF-a [15] and IL-6 [16—18], which could in turn
modulate the synthesis and expression of adhesion molecules on
the tubular epithelial cell surface in an autocrine manner.
The effects of hypoxia on the expression of adhesion molecules
have been studied in vitro on cultured endothelial cells. Exposure
of endothelial cells to hypoxia followed by re-oxygenation induces
an increase in the adhesiveness of endothelial cells for neutrophils
and related leukocytic cell lines [19—21] as well as for lymphocytes
[22]. This increased adhesiveness is associated with the stimula-
tion of transcription and of expression of the adhesion molecules
ICAM-1 [19, 20] and E-selectin, formerly named endothelial
leukocyte adhesion molecule-i (ELAM-1) [19]. The release of
interleukin- Ia [19] and platelet activating factor (PAF) [211 has
been shown to mediate the effects of hypoxia on the synthesis and
expression of adhesion molecules by cultured endothelial cells. In
other studies, hypoxia has been shown to activate the transcription
and synthesis of inflammatory mediators such as lL-8 and MCP-1
[23] through direct activation of the transcription factor NF-KB by
phosphorylation of its inhibitor 1KB [23, 24].
Renal proximal tubular cells are especially sensitive to exposure
to hypoxia [3, 25, 26]. As stated above, these cells may secrete
various cytokines, including potent inducers of the expression of
ICAM-1 such as TNF-a, the secretion of which could be stimu-
lated by hypoxia. Therefore, the current studies were designed to
examine the effects of hypoxia on the expression of ICAM-1 by
tubular cells and to define the mechanism involved. The studies
demonstrate that hypoxia induces the synthesis and expression of
the adhesion molecule ICAM-l by cultured human tubular cells,
independent of the secretion of the cytokines TNF-a, IL-6, and
IL-I f3. Pyrrolidinc dithiocarbamate (PDTC), an antioxidant that
inhibits the activation of transcription by NF-KB, reduced the
effect of hypoxia on KAM-1 expression.
1703
1704 Combe et al: Hypoxia-induced ICAM-1 on tubular cells
Methods
Materials
Cell culture media were obtained from Gibco (Irvine, UK).
Defined medium additives, collagenase type II, bovine collagen
type I were from Sigma (St. Louis, MO, USA). The recombinant
human cytokines tumor necrosis factor-a (TNF-a) and interleu-
kin-6 (IL-6) were purchased from R & D Systems (Abingdon,
UK).
Cell culture
Human tubular cells were isolated as previously described [27]
by a modification of the method of Detrisac et al [28]. The outer
cortex was dissected from the normal pole of kidneys removed for
treatment of carcinoma or from donor kidneys deemed unsuitable
for transplantation and cut into 1 mm3 pieces. These were
suspended in type II coliagenase, 1 mg/ml at 37°C for 30 minutes.
The digest was passed through a series of sieves of diminishing
mesh sizes (500, 250, 90 /xm) and the giomeruli removed on the
top of the 90 jxm mesh. The tubular fragments that passed
through the sieves were seeded into 75 cm2 flasks that had been
previously coated with bovine collagen type I and adsorbed fetal
calf serum proteins.
The cells were grown in DMEM:F12 with the addition of 25 mM
HEPES buffer, insulin (5 jxg/ml), transferrin (5 xg/m1), selenium
(5 ng/ml), tri-iodo-thyronine (4 pg/mi), hydrocortisone (36 ng/ml),
benzyl penicillin (100 IU/ml) and streptomycin (50 ,ag/ml). At the
third passage and thereafter, 5% heat-inactivated fetal calf serum
was added to the above medium since it was found that the serum
was required to achieve cell confluence. Experiments were per-
formed with cells from the second to the fifth passages.
Cell characterization
Cytospins of cells were prepared for immunostaining with
mouse monoclonal antibodies to cytokeratin (clone MNF116;
Dako, Glostrup, Denmark), human epithelial membrane antigen
(clone E29; Dako), and factor VIII related antigen (clone F8/86;
Dako). Standard histochemistry was used to detect nonspecific
esterase [29, 30]. Cultured human endothelial cells (gift of Dr
Bryan Williams, University of Leicester, UK) were used as a
positive control for factor VIII related antigen staining.
Cyclic 3'S' adenosine monophosphate (cAMP) production by
the cells was measured in response to a 15 minute stimulation by
parathyroid hormone (10 M) or arginine vasopressin (10—6 M) in
the presence of the phosphodiesterase inhibitor IBMX (isobutyl-
3-methyl xanthine 5 mM). cAMP was measured by radioimmuno-
assay (Amersham, UK) after extraction with 0.01 N HC1 as
previously described [31].
Exposure of cells to hypoxia/re-oxygenation
Hypoxic culture conditions were produced by placing the cells
in a mini-incubator perfused with a 95% N2/S% CO2 gas mixture
saturated with water. Temperature was maintained at 37°C. The
cells were exposed to hypoxia for a maximum of 24 hours, during
which time oxygen tension in the culture medium was 3.1 0.5
kPa (vs. 17.5 1.4 kPa in 95% air/S% CO2 control conditions).
Re-oxygenation was performed by placing the cells in an incuba-
tor gassed with 95% air/S% CO2.
Cell viability in hypoxic and control conditions was assessed by
trypan blue exclusion and the measurement of lactate dehydro-
genase activity in the supernatants.
Flow cytometly analysis
For flow cytometry analysis, cells were cultured in six well plates
(6 >< 10 cm2). At the end of the experimental period, cells were
rinsed three times with HBSS at 4°C, then detached with trypsin-
EDTA for five minutes at 37°C. Trypsinization was stopped by the
addition of PBS containing 1% NaN3 and 10% FCS. Thereafter,
cells were pelleted, centrifugated and incubated for 10 minutes at
4°C in PBS containing 1% NaN3 and 1% goat serum. After two
washes with PBS/1% NaN3, cells were incubated with the primary
antibody for 30 minutes at 4°C. Antibodies used were a murine
monoclonal anti-ICAM-1 (BBIG-I1; R&D Systems clone) at a
concentration of 1 pg/SO pl/2S,000 cells, a murine monoclonal
anti-VCAM-1 (clone BBE 3; R&D Systems) at a concentration of
I pg/SO 1.d/25,000 cells and, as a control, a murine monoclonal
anti-human von Willebrand factor (clone F8/86; Dako) at a
concentration of 0.3 pg/SO d/25,000 cells. After three washes with
PBS/1% NaN3, cells were incubated for 30 minutes at 4°C with a
FITC-labeled goat monoclonal anti-murine IgG, then washed
twice and fixed with PBS containing 1% NaN3 and 1% parafor-
maldehyde.
Flow cytometry analysis was performed with a FACScan,
(Becton-Dickinson, Mountain View, CA, USA). To standardize
cell-associated immunofluorescence between different experi-
ments, the instrument was calibrated with quantitative fluorescein
microbead standards [32, 331 (Flow Cytometry Standards Corp,
Research Triangle Park, NC, USA). A standard curve was con-
structed by plotting FITC molecules per bead versus log of mean
fluorescence intensity. The presence of ICAM-l on the cells was
expressed as the number of fluorescent molecules (fm) per cell.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Tubular cells cultured in six well plates were rinsed three times
with PBS at 4°C, and then harvested with a sterile rubber
policeman. Polyadenylated RNA was then prepared using a
Micro-FastTrack kit (Invitrogen, San Diego, CA, USA). Single
strand cDNA was then synthetized by reverse transcription using
a method modified from Sambrook, Fritsch and Maniatis [34].
Briefly the RNA sample was incubated for one hour at 42°C with
1 pg of polyA+ RNA, 20 jxg/ml oligodeoxythymidine and 200
units M-MLV RNase H-reverse transcriptase (Gibco BRL, Gaith-
ersburg, MD, USA). Amplifications were performed on a 50-rd
reaction mixture containing 5 .t1 of cDNA-RNA hybrids, 200 I.tM
dATP, dCTP, dGTP, 150 jxM dTTP, 50 /.LM biotinylated-11-dUTP,
20 mivi Tris-HCI pH 8.55, 2.5 mvi MgCl2, 16 mrvi (NH4)2S04, 150
pg/mi bovine serum albumin (BSA), I m of each oligonucleotide
primer and 2.5 units of Thermus aquaticus (BioTaq"M) polymer-
ase (Bioprobe Systems). The reaction was subjected to defined
rounds of temperature cycling with a thermocycler. A typical
temperature cycle was 30 seconds at 95°C (denature), five seconds
at 56°C (anneal) and one minute at 72°C (elongate) [35J.
The oligonucleotide primers for the PCR are shown in Table 1
[35, 361. Oligodeoxynucleotides were synthesized according to a
published sequence for ICAM-1 [37]. Human glyceraldehyde-3-
phosphate dehydrogenase (G3PDH) primers were provided by
Clontech Laboratories, Inc. (Palo Alto, CA, USA).
The exponential range of amplification was determined for
each primer set. The number of cycles was adjusted so samples
were analyzed in the linear phase of amplification. As previously
reported [351, the number of cycles was 18 for G3PDH, and 22 for
ICAM-l.
Quantitation of cDNA-PCR amplified products
Ten microliters of each PCR reaction mixture was electropho-
resed in agarose gel, blotted onto a nylon membrane (Hybond
N+; Amersham), and then coupled to streptavidin-horseradish
peroxidase complex (Amersham). The relative density of the
signals from each lane of PCR products were determined by
scanning densitometry [35].
Standard curves for ICAM-1 and G3PDH were constructed by
analysis of serial dilutions of purified cDNA. cDNA was quanti-
fied over the linear portion of the standard curves. Outside this
range, cDNA was quantified on diluted samples. G3PDH, a
ubiquitous and highly expressed gene, was used as internal
standard, and the ICAM-1 signals were normalized to G3PDH
values. The data were presented as relative values (ICAM-1/
G3PDH) and plotted against time. The results from three inde-
pendent amplifications on two separate studies are presented.
Cytokine measurements
Cytokine concentrations in the culture medium (IL-ill, TNF-cs
and IL-6) were measured using commercially available ELISAs
(R&D Systems).
Blocking experiments
The biological effects of TNF-a were blocked using a neutral-
ising antibody (clone BDA 13; R&D Systems) at a concentration
of 10 JLg/ml, that is, 10 times the concentration used to neutralize
100% of the biological activity of 0.25 ng/ml recombinant human
TNF-a. In separate experiments it was confirmed that this anti-
body did not modify any flow cytometry parameters (data not
shown).
PDTC, an antioxidant, was used as an inhibitor of the transcrip-
tion factor NF-KB [38]. This compound blocks the dissociation of
IKBa from the NFkB protein, inhibiting the effect of various
agonists such as phorbol esters, IL-i and TNF-a [38]. At the
concentration used (100 ELM), it is not toxic to cell cultures.
Analysis of results
Results are expressed as mean SD and have been analyzed
with analysis of variance, paired or unpaired t-test or Scheffé's
test, as appropriate, with a significance level of P < 0.05.
Results
Cell characterization
The human kidney cortical cells formed monolayers that had
the typical cobblestone appearance of epithelial cell monolayers.
The cells formed domes on tissue culture plates. They stained
positively for epithelial membrane antigen and cytokeratin but
negatively for Factor VIII related antigen. The cells stained
positively for nonspecific esterase, which distinguishes them from
glomerular epithelial cells [28]. Exposure of the cells to parathy-
roid hormone in the presence of IBMX resulted in an approxi-
mately 6.8-fold increase in cAMP concentration compared to cells
exposed to IBMX only. A 2.7-fold increase in cAMP was seen
upon exposure to AVP. These results would indicate that the cells
are predominantly of proximal tubular origin [27, 39, 40].
Effects of hypoxia and re-oxygenation on cell viability
After 24 hours of exposure to hypoxic culture conditions, cell
viability was not affected: trypan blue exclusion was greater than
98%, and lactate dehydrogenase activity in the supernatants was
comparable in hypoxic cells and cells cultured in normal condi-
tions (101 39 U/mi vs. 86 39 U/mI, P = NS, results of 3
experiments performed in triplicate). When hypoxic cells were
re-oxygenated, trypan blue exclusion was maintained, lactate
dehydrogenase activity in the supernatants being not different
from control or hypoxic cells (92 42 U/mI).
Induction of ICAM-] upon exposure of tubular cells to hypoxia
Under control conditions it was found that cortical tubular cells
strongly expressed ICAM-1 (1.33 0.19 106 fm per cell), con-
firming previously published data [8, 9, 11—13, 41]. This is 50-fold
greater expression than is seen in human mesangial cells from the
same kidney (data not shown). Exposure of cortical tubular cells
to hypoxic culture conditions induced a time-dependent increase
in the expression of ICAM-1 (Fig. 1), with 1.60 0.01 106 fm per
cell after four hours (P < 0.01), 1.68 0.15 106 fm per cell after
12 hours (P < 0.01), and i.88 0.17 106 fm per cell after 24 hours
(P < 0.0001). When the cells were re-oxygenated in a 95% air/5%
CO2 atmosphere, no further increase in ICAM-1 expression was
demonstrated, and indeed, ICAM-1 expression returned to con-
trol levels (Fig. 2).
While exposure of cortical tubular cells to hypoxia induced
membrane expression of ICAM-1, the expression of VCAM-1 was
not modified (control 3.08 1.74 i05 fm per cell, 24 hr of hypoxia
2.92 1.20 i0 fm per cell).
The induction of ICAM-1 expression on exposure of cortical
tubular cells to hypoxia was less than that seen when the cells were
exposed to 10 ng/ml TNF-a for 24 hours (3.36 0.72 106 fm per
cell, P < 0.0001). This TNF-a-induced ICAM-1 expression was
comparable to that reported in previous studies [9, 11—13, 41].
in parallel with the increase in membrane expression of
ICAM-1, there was a time-dependent induction of ICAM-1
mRNA in hypoxic tubular cells, compared to normoxic cells (Fig.
3). The ICAM-i/GAPDH mRNA ratio increased up to 12 hours
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Table 1. Oligonucleotides of 5' primers and 3' primers of target genes
Sequence (5'-3') Nucleotides
(+) GTCCCCCTCAAAAGTCATCC 105—124 943








































Fig. 1. Time-dependent quantitative membrane expression of ICAM-1 by
cortical tubular cells exposed to hypoxic culture conditions. Results are
presented as the mean SD of 3 experiments, each performed in
triplicate. *p < ***p < 0.0001.
0 4 8 12 24 TNF long/mi
Time, hours 24 hrs
Fig. 3. Time-course of ICAM-1 mRNA expression in cortical tubular cells
exposed to hypoxia, as determined by RT-PCR analysis. ICAM-1 mRNA is
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Fig. 4. Concentration of TNF-a in the supernatants of tubular cells exposed
to hypoxia. Results are presented as mean SEM of 3 experiments, each
performed in triplicate. Effect of time: P < 0.002 by ANOVA.
secretion TNF-cs by tubular cells in response to hypoxia did not
mediate the effect of hypoxia on ICAM-1 expression.
IL-6 concentrations in the culture supernatants did not vary
between normoxic conditions (3630 870 pg/mI) and following
exposure to hypoxia for four hours (2920 480 pglml), 12 hours
(2032 289 pg/mI) or 24 hours (3121 2002 pg/mI), suggesting
that IL-6 was not involved in mediating hypoxia induced ICAM-1
expression. Furthermore, recombinant IL-6 at a concentration of
10 ng/ml for 24 hours had no effect on membrane ICAM-1
expression (data not shown).
IL-1J3 is known to be a powerful inducer of the expression of
ICAM-1 in several cell types, and was able to induce ICAM-1
expression on these cultured cortical tubular cells (data not
shown). Howevcr, immunoreactive IL-1f3 was not detected in the
culture medium of the cortical tubular epithelial cells, either
under hypoxic or normoxic culture conditions.
Therefore, neither TNF-cs, nor IL-6, nor JL-1/3 could be
0.5
Hypoxia Hypoxia 24 hrs
24hrs Reoxl2hrs
Fig. 2. Membrane expression of ICAM-] by cortical tubular cells exposed to
hypoxic culture conditions and re-oxygenated. Results are presented as
mean sn of 2 experiments, each performed in triplicate. < 0.0001.
mRNA ratio after exposure of the cells to TNF-rs for 24 hours is
shown for comparison.
Role of cytokines in the induction of the expression of ICAM- I by
hypoxia
Exposure of tubular cells to hypoxia resulted in a small, hut
significant (by ANOVA) increase in TNF-a concentration in the
culture medium with time (Fig. 4). To assess the contribution of
raised TNF-a levels in the induction of ICAM-1 by hypoxia, an
anti-TNF-a neutralizing antibody was used (Fig. 5). Although at
the concentration used, the antibody was effective in preventing
the induction of the expression of ICAM-1 by 10 nglml recombi-
nant TNF-a at 24 hours, it had no effect on hypoxia-induced
expression of ICAM-l. These experiments demonstrate that the
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Fig. 5. Membrane expression of ICAM-1 by tubular cells was measured after
24 hours of normoxic conditions, hypoxic conditions, or 10 ng/ml recombi-
nant TNF-a in the absence (LI) or presence () ofan anti-TNF-a antibody(**P < 0.01, ***p < 0.001).
implicated in the induction of synthesis and expression of ICAM-1
seen on exposure of cortical tubular cells to hypoxia.
Effect of PDTC on hypoxia-induced expression of ICAM-1
Hypoxia has previously been shown to cause direct activation of
NFKB in other cell culture systems [23, 24]. One hundred
micromoles of PDTC was used to inhibit the activation of NFKB
[38] in cortical tubular cells subjected to hypoxic or normoxic
culture conditions. No variation in cell morphology was observed,
nor in LDH activity in the supernatants, confirming that PDTC
was not toxic to the cells, either hypoxic or normoxic (data not
shown). The increase in ICAM-1 expression induced by hypoxia
was nearly completely abolished when the cells were exposed to
PDTC (Fig. 6). PDTC induced a small but significant decrease in
the expression of ICAM-1 in normoxic conditions, and also had an
inhibitory effect on the action of TNF-a. (TNF-a requires the
activation of NFKB to induce the synthesis of ICAM-1.)
Discussion
An increase in the expression of ICAM-1 by renal tubular cells
in response to hypoxia could contribute to the intense pen-tubular
and interstitial leukocytic infiltration that is observed in experi-
mental models of renal hypoxia [2, 3, 42]. A peritubular leukocyte
infiltrate may directly modulate tubular epithelial cell function
[43] and could also result in direct tubular cell damage and
promote progressive interstitial damage [441. Thus, the protective
effect of anti-ICAM-1 antibodies in experimental renal hypoxia
[21 could be explained in part by decreased adhesion of leukocytes
to renal tubular cells, in addition to decreased adhesion of
leukocytes to endothelial cells. It has also been suggested that the
effects of ischemia on the function of renal allografts after
transplantation may he mediated in part via the induction of
ICAM-1 expression on tubular cells as a result of hypoxia [45].
Such a process might favor rejection; clinical observations would
suggest that the degree of ischemia influences not only the
incidence of acute renal failure in the early days following
transplantation, but also the number of rejection episodes and the
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Fig. 6. Membrane expression of ICAM-] by tubular cells after 24 hours
exposure to normoxic conditions, hypoxic conditions, or 10 ng/ml recombi-
nant TNF-a, in the absence (LI) or presence () of100 /.LM PDTC (***P <
0.0001 vs. control, 000p < 0.001 vs. without PDTC).
The current study provides direct evidence that exposure of
cultured cortical tubular cells to hypoxia results in an increase in
membrane expression of the adhesion molecule ICAM-1 and an
increase in ICAM-1 mRNA. On the contrary, the expression of
VCAM-1, another adhesion molecule, was not influenced by
hypoxia.
Hypoxia is known to induce the transcription of the adhesion
molecules ICAM-1 and E-selectin in cultured endothelial cells.
This appears to be dependent on the activation by hypoxia of
autocrine cytokine loops, particularly IL-la [19]. We hypothe-
sized that a similar mechanism of autocrine cytokine stimulation
might mediate the effects of hypoxia on tubular epithelial cells.
TNF-cr has previously been implicated in the regulation of
ICAM-1 expression by these cells [14] and TNF-a is also known to
be a potent inducer of the synthesis of other cytokines. The
current studies confirmed that TNF-cc was able to induce the
synthesis of ICAM-1 by human tubular cells in culture. However,
although hypoxia induced a small, but significant increase in the
secretion of TNF-a by the tubular epithelial cells into the culture
medium (Fig. 4), when the effects of TNF-a were blocked with a
monoclonal antibody the effect of hypoxia on ICAM-1 expression
was not modified. The same concentration of monoclonal anti-
body was able to totally block the effect exogenously added
recombinant TNF-a on ICAM-1 expression. Therefore, the stim-
ulation of the expression of ICAM-1 by tubular epithelial cells in
culture by hypoxia does not depend on the autocrinal secretion of
TNF-a.
Cultured renal tubular cells also synthesize IL-6 in large
amounts [16—18], and as IL-6 may modulate the expression of
ICAM-1 in other culture systems [47], the role of IL-6 as a
mediator of the effects of hypoxia was also examined. In the
current experiments high concentrations of IL-6 were found in the
supernatants of cultured renal tubular cells, confirming previous
observations [16—18]. However, the levels of IL-6 were not
influenced by exposure of the cells to hypoxia. Furthermore,
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pharmacological doses of recombinant IL-6 had no effect on the
expression of ICAM-1 by tubular cells, effectively ruling out a
contribution of this cytokine in mediating the effects of hypoxia.
Since IL-113 is a powerful inducer of the synthesis of adhesion
molecules, the effect of hypoxia on the synthesis of IL-113 was also
assessed. However, no IL-113 was detected in the culture medium
of either control cells or of cells cultured under hypoxic condi-
tions.
Recent studies have shown that hypoxia itself may directly
activate gene transcription. Exposure of cultured endothelial cells
to hypoxia induces direct activation of the nuclear factor NF-KB
through phosphorylation of its inhibitor 1KB [23, 241. In turn the
activation of NF-KB stimulates the transcription and secretion of
the cytokines IL-8 and MCP-1 [23]. NF-KB sites are also present
in the promoter of the ICAM-1 gene [48]. Therefore, it is possible
that hypoxia could directly activate the transcription of ICAM-1,
through activation of NF-KB. In support of this hypothesis, when
PDTC was added to the supernatants of cultured tubular cells, the
effect of hypoxia on ICAM-1 expression was abrogated. PDTC
may have directly blocked the activation of the transcription
factor NFKB, as suggested by previous studies [38], or may have
acted through its antioxidant properties, resulting in lower acti-
vation of NFKB. This suggests that hypoxia could directly activate
the transcription of ICAM-l through activation of NFKB.
In conclusion, hypoxia can stimulate the expression of ICAM-1
on cortical tubular epithelial cells. The modulation of autocrinal
production of cytokines TNFc, IL-1/3 and IL-6 does not play a
role in the stimulation of the synthesis and expression of ICAM-1
by tubular epithelial cells in response to hypoxia. The activation of
NFKB is, however, probably required. These observations may
explain in part the perituhular infiltration of leukocytes that is
seen following an ischemic insult to the kidney. Modulation of this
process may have therapeutic implications for abrogating post-
ischemic renal dysfunction.
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